ID/EIS Joint Fellowship

IDSA, in partnership with CDC, has created a joint infectious diseases and CDC Epidemic Intelligence Service fellowship pilot program for physicians pursuing an ID fellowship. The ID/EIS training program combines the two-year ID fellowship and two-year EIS program for a structured four-year training opportunity.

The ID/EIS joint fellowship provides an unmatched opportunity for physicians interested in infectious diseases to expand their public health training, serve on the frontlines of global outbreaks, and join an esteemed network of more than 4,000 EIS alumni, including state public health officials, CDC directors, acting surgeons general, WHO assistant directors-general, and more.

Background

Funded by CDC, the joint ID/EIS fellowship pilot program is developing future public health leaders. The four-year ID/EIS fellowship program begins with a two-year ID fellowship then continues with the two-year EIS program. During the EIS training, joint fellows will directly address public health threats, working either in field locations at state and local public health departments or at the CDC headquarters in Atlanta.

Eleven ID fellowship programs, listed below, are currently participating in the ID/EIS pilot. Additional programs will be added in the future.  

• Emory University School of Medicine 
• Massachusetts General Hospital/Brigham and Women’s Hospital  
• Rush University Medical Center/Cook County Health 
• Stanford Medicine  
• University of New Mexico Health Sciences Center 
• University of North Carolina-Chapel Hill 
• University of Washington 
• University of Wisconsin – Madison 
• Vanderbilt University Medical Center 
• Weill Cornell/New York Presbyterian 
• West Virginia University  
  

There are several benefits to the joint ID/EIS Fellowship program for applicants:

1. Applicants will apply to the EIS and ID fellowship programs at the same time. One application period can inform career plans for 4 years.
2. EIS field placements will generally be available near the ID fellowship program locations, so joint fellows do not have to relocate. CDC will guarantee an EIS placement in Atlanta if the joint fellow prefers, or if a field placement near the ID program is not possible.
3. Joint fellows can incorporate their EIS plans into research and training activities during the ID fellowship.

Information for Joint ID/EIS Applicants

This new opportunity pairs an ID fellowship with the EIS program. For the first year of the pilot, 11 ID fellowship programs were selected to participate in the pilot. Learn about the programs and the application process.

Applications are not currently being accepted to the joint program but may be in the future.

Information for ID Fellowship Programs

The competitive application process to become part of the joint fellowship has closed for calendar year 2023. Selected ID fellowship programs were notified in June 2023.

IDSA and CDC may expand the number of participating programs in future years. If the pilot is expanded further, a competitive application process will be held, with updates shared on this website. 

More information for ID fellowship programs can be found here. 

Let’s Talk ID | President’s Podcast

ID/EIS program leaders discuss the joint fellowship in this Let’s Talk ID episode. IDSA President Carlos del Rio, MD, FIDSA, speaks with Molly Paras, MD, FIDSA, Program Director of the Massachusetts General Hospital/Brigham and Women’s Hospital Infectious Diseases Fellowship, and Eric Pevzner, PhD, MPH, chief of the Epidemiology and Laboratory Workforce Branch in the Division of Workforce Development at CDC, about the joint fellowship and the value it will bring to public health.

The joint ID/EIS fellowship pilot program is funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000574). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The information on this page does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.